Insights

Rapid Market Expansion BIA Separations is actively expanding its manufacturing capabilities in Slovenia and investing in technological development, indicating a strong growth trajectory and increasing production capacity that can benefit from additional specialized equipment, consumables, and service support.

Strategic Collaborations Recent collaborations with Arnav Biotech and Biomay AG highlight BIA’s focus on high-value therapeutic projects such as mRNA therapeutics and plasmid DNA, opening opportunities to provide tailored purification solutions, custom columns, and analytical technologies for advanced biopharmaceutical applications.

Innovation Leadership The launch of novel technologies like PrimaS ligand and Cornerstone process development services demonstrates BIA’s commitment to innovation, creating demand for cutting-edge chromatography media, process development expertise, and technical support that can be supplied to accelerate client R&D and commercialization.

Niche Market Focus With a specialized product portfolio focused on viral vectors, plasmid DNA, and monoclonal antibodies, BIA provides targeted solutions for biopharma companies working on gene therapies and vaccines, representing a promising avenue for sales of high-capacity columns, process analytical tools, and process monitoring systems.

Growth in mRNA Sector BIA’s recent initiative to develop purification and analytical platforms for mRNA therapeutics positions the company as a key player in this rapidly expanding market segment, offering opportunities to supply high-throughput chromatography systems, reagents, and associated process analytics tailored to mRNA production needs.

BIA Separations Tech Stack

BIA Separations uses 8 technology products and services including RSS, Cloudflare, Mailjet, and more. Explore BIA Separations's tech stack below.

  • RSS
    Content Management System
  • Cloudflare
    Content Management System
  • Mailjet
    Email
  • Google Maps
    Maps
  • Priority Hints
    Performance
  • Animate.css
    UI Frameworks
  • Bootstrap
    UI Frameworks
  • Contact Form 7
    Web Platform Extensions

Media & News

BIA Separations's Email Address Formats

BIA Separations uses at least 1 format(s):
BIA Separations Email FormatsExamplePercentage
First.Last@biaseparations.comJohn.Doe@biaseparations.com
100%

Frequently Asked Questions

Where is BIA Separations's headquarters located?

Minus sign iconPlus sign icon
BIA Separations's main headquarters is located at 21 Mirce Ajdovščina, Ajdovščina 5270 Slovenia. The company has employees across 2 continents, including EuropeOceania.

What is BIA Separations's phone number?

Minus sign iconPlus sign icon
You can contact BIA Separations's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is BIA Separations's official website and social media links?

Minus sign iconPlus sign icon
BIA Separations's official website is biaseparations.com and has social profiles on LinkedIn.

What is BIA Separations's SIC code NAICS code?

Minus sign iconPlus sign icon
BIA Separations's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIA Separations have currently?

Minus sign iconPlus sign icon
As of December 2025, BIA Separations has approximately 54 employees across 2 continents, including EuropeOceania. Key team members include Project Manager: K. V.Project Manager, Process Development: L. R.Office Manager Bia Separations Us: J. K.. Explore BIA Separations's employee directory with LeadIQ.

What industry does BIA Separations belong to?

Minus sign iconPlus sign icon
BIA Separations operates in the Biotechnology Research industry.

What technology does BIA Separations use?

Minus sign iconPlus sign icon
BIA Separations's tech stack includes RSSCloudflareMailjetGoogle MapsPriority HintsAnimate.cssBootstrapContact Form 7.

What is BIA Separations's email format?

Minus sign iconPlus sign icon
BIA Separations's email format typically follows the pattern of First.Last@biaseparations.com. Find more BIA Separations email formats with LeadIQ.

How much funding has BIA Separations raised to date?

Minus sign iconPlus sign icon
As of December 2025, BIA Separations has raised $1.7M in funding. The last funding round occurred on Sep 21, 2015 for $1.7M.

When was BIA Separations founded?

Minus sign iconPlus sign icon
BIA Separations was founded in 1998.

BIA Separations

Biotechnology ResearchAjdovščina, Slovenia51-200 Employees

BIA Separations is a worldwide provider of solutions for biopharmaceutical companies. Our prepacked chromatographic columns enable high speed purifications up to industrial scale (non cGMP and cGMP compliant) of large biomolecules such as viruses (rAAV, adenovirus, influenza, lentivirus, bacteriophages), plasmid DNA and larger proteins (mAbs, IVIG, IgM, PEGylated proteins). Our CIM® Monolithic Columns technology exhibits unrivaled high operational flow rates, binding capacity and separation resolution, enabling highly economic processes.
BIA Separations offers a whole toolset for chromatographic analyses of molecules in up- and downstream processes in minutes. Our analytical columns (CIMacTM) together with an analytical HPLC system (PATfixTM) help you understand your bioprocess through real-time monitoring and understanding of each of your individual process steps.
On top of that, we are pleased to share our combined expert knowledge and accumulated experience in biomolecule purification and method validation with our customers. We are committed to serve with the most accurate solutions matching your individual needs.
BIA Separations produces pre-packed HPLC chromatographic columns that enable high speed purifications of virus vaccines, viral vectors for gene therapy, bacteriophages, VLPs, pDNA, mAbs (IgG, IgM) and PEGylated proteins accompanied with efficient removal of RNA up to industrial scale. We are a worldwide provider of simple solutions for biopharmaceutical companies in the fields of HPLC based downstream purification processes and process analytical technology (PAT).

Section iconCompany Overview

Headquarters
21 Mirce Ajdovščina, Ajdovščina 5270 Slovenia
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1998
Employees
51-200

Section iconFunding & Financials

  • $1.7M

    BIA Separations has raised a total of $1.7M of funding over 2 rounds. Their latest funding round was raised on Sep 21, 2015 in the amount of $1.7M.

  • $1M

    BIA Separations's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1.7M

    BIA Separations has raised a total of $1.7M of funding over 2 rounds. Their latest funding round was raised on Sep 21, 2015 in the amount of $1.7M.

  • $1M

    BIA Separations's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.